TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pharmaust Limited ( (AU:NUZ) ) has provided an update.
Neurizon Therapeutics Limited has announced a proposed issue of 43,333,334 ordinary fully paid securities, with the issuance date set for September 24, 2025. This move, disclosed to the ASX, is part of their strategic financial operations, potentially impacting their market positioning and stakeholder interests.
The most recent analyst rating on (AU:NUZ) stock is a Buy with a A$0.52 price target. To see the full list of analyst forecasts on Pharmaust Limited stock, see the AU:NUZ Stock Forecast page.
More about Pharmaust Limited
Average Trading Volume: 305,562
Technical Sentiment Signal: Sell
Current Market Cap: A$68.92M
Learn more about NUZ stock on TipRanks’ Stock Analysis page.